NewcelX Ltd. (NCEL)
NASDAQ: NCEL · Real-Time Price · USD
2.650
-0.030 (-1.12%)
At close: Nov 18, 2026, 4:00 PM EST
2.700
+0.050 (1.89%)
Pre-market: Nov 19, 2026, 4:02 AM EST
NewcelX Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
12
Market Cap
15.31M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
NCEL News
- 9 days ago - NewcelX Announces Pricing of $1.55 Million Equity Financing at 20% Premium Pricing to Market - GlobeNewsWire
- 14 days ago - NewcelX to divest legacy Mazindol portfolio for up to $55M in milestones - TheFly
- 14 days ago - NewcelX Enters into Binding Term Sheet to Divest Legacy Mazindol Portfolio (CVR), Providing for Upfront Cash, Equity Ownership and Up to $55 Million in Potential Milestone Payments - GlobeNewsWire
- 7 weeks ago - NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes - GlobeNewsWire
- 3 months ago - NewcelX registers to sell 694K common shares for holders - TheFly
- 3 months ago - NewcelX announces pricing of $1.4M equity financing - TheFly
- 3 months ago - NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing - GlobeNewsWire
- 4 months ago - NewcelX announces Brazil patent for cell selection, enrichment technology - TheFly